
Kara E. Geisel
Supervisory Patent Examiner (ID: 16963, Phone: (571)272-2416 , Office: P/2877 )
| Most Active Art Unit | 2877 |
| Art Unit(s) | 2877, RD00 |
| Total Applications | 972 |
| Issued Applications | 745 |
| Pending Applications | 81 |
| Abandoned Applications | 153 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19584835
[patent_doc_number] => 20240382392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => METHOD FOR PRODUCING EMULSION COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/703046
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18703046
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/703046 | METHOD FOR PRODUCING EMULSION COMPOSITION | Oct 23, 2022 | Pending |
Array
(
[id] => 18972262
[patent_doc_number] => 20240052354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => COMPOSITIONS AND METHODS TO TREAT CANCER
[patent_app_type] => utility
[patent_app_number] => 18/048015
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048015
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048015 | COMPOSITIONS AND METHODS TO TREAT CANCER | Oct 18, 2022 | Abandoned |
Array
(
[id] => 19641258
[patent_doc_number] => 20240415778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => ORAL PREPARATION CONTAINING PROGESTOGEN, AND PREPARATION METHOD AND USE
[patent_app_type] => utility
[patent_app_number] => 18/706344
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706344
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/706344 | ORAL PREPARATION CONTAINING PROGESTOGEN, AND PREPARATION METHOD AND USE | Oct 16, 2022 | Pending |
Array
(
[id] => 18449457
[patent_doc_number] => 20230190733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/047078
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047078
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047078 | Methods and compositions for treating cancer | Oct 16, 2022 | Issued |
Array
(
[id] => 18664846
[patent_doc_number] => 11771711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Substituted pyridines as DNMT1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/966504
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 24023
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966504 | Substituted pyridines as DNMT1 inhibitors | Oct 13, 2022 | Issued |
Array
(
[id] => 20491556
[patent_doc_number] => 12533412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Ultrasound-responsive liposome nanoparticles and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/570072
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 0
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570072
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570072 | Ultrasound-responsive liposome nanoparticles and preparation method and use thereof | Oct 12, 2022 | Issued |
Array
(
[id] => 18391280
[patent_doc_number] => 20230159498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER
[patent_app_type] => utility
[patent_app_number] => 17/961437
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961437 | SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER | Oct 5, 2022 | Pending |
Array
(
[id] => 18510086
[patent_doc_number] => 20230226185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHODS AND COMPOSITIONS FOR INDUCING FERROPTOSIS IN VIVO
[patent_app_type] => utility
[patent_app_number] => 17/937599
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937599 | METHODS AND COMPOSITIONS FOR INDUCING FERROPTOSIS IN VIVO | Oct 2, 2022 | Abandoned |
Array
(
[id] => 18420061
[patent_doc_number] => 20230174522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Benzisoxazole Sulfonamide Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/946101
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946101 | Benzisoxazole sulfonamide derivatives | Sep 15, 2022 | Issued |
Array
(
[id] => 19120983
[patent_doc_number] => 11964953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Substituted aminothiazoles as DGKzeta inhibitors for immune activation
[patent_app_type] => utility
[patent_app_number] => 17/944922
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 114483
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/944922 | Substituted aminothiazoles as DGKzeta inhibitors for immune activation | Sep 13, 2022 | Issued |
Array
(
[id] => 19658819
[patent_doc_number] => 20240425884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => EFFICIENT HIGH-THROUGHPUT ELECTROPORATION FOR EV AND EXOSOME CARGO LOADING
[patent_app_type] => utility
[patent_app_number] => 18/683545
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683545 | EFFICIENT HIGH-THROUGHPUT ELECTROPORATION FOR EV AND EXOSOME CARGO LOADING | Sep 6, 2022 | Pending |
Array
(
[id] => 19691358
[patent_doc_number] => 20250009903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => PEPTIDE-BINDING HYBRID LIPOSOME EXOSOME, PEPTIDE-BINDING EXOSOME, COMPOSITION CONTAINING SAME, AND METHOD OF FORMING SAME
[patent_app_type] => utility
[patent_app_number] => 18/684960
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/684960 | PEPTIDE-BINDING HYBRID LIPOSOME EXOSOME, PEPTIDE-BINDING EXOSOME, COMPOSITION CONTAINING SAME, AND METHOD OF FORMING SAME | Aug 22, 2022 | Pending |
Array
(
[id] => 19798813
[patent_doc_number] => 20250064738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A
[patent_app_type] => utility
[patent_app_number] => 18/683745
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683745 | MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A | Aug 16, 2022 | Pending |
Array
(
[id] => 20108153
[patent_doc_number] => 12358859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Series of compounds for treatment of skin diseases and other conditions
[patent_app_type] => utility
[patent_app_number] => 17/887480
[patent_app_country] => US
[patent_app_date] => 2022-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 10293
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/887480 | Series of compounds for treatment of skin diseases and other conditions | Aug 13, 2022 | Issued |
Array
(
[id] => 19762121
[patent_doc_number] => 12220391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Compositions and methods of use of b-hydroxy-b-methylbutyrate (HMB) for modulating autophagy and lipophagy
[patent_app_type] => utility
[patent_app_number] => 17/882905
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 6432
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/882905 | Compositions and methods of use of b-hydroxy-b-methylbutyrate (HMB) for modulating autophagy and lipophagy | Aug 7, 2022 | Issued |
Array
(
[id] => 19870430
[patent_doc_number] => 12263269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Particle-form hybrid-scale fiber matrix
[patent_app_type] => utility
[patent_app_number] => 17/877485
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 9051
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/877485 | Particle-form hybrid-scale fiber matrix | Jul 28, 2022 | Issued |
Array
(
[id] => 19479667
[patent_doc_number] => 20240327709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/291160
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291160
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291160 | NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF | Jul 26, 2022 | Pending |
Array
(
[id] => 19496350
[patent_doc_number] => 20240335368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => COSMETIC TREATMENT METHOD COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING AT LEAST ONE ANTIOXIDANT AND A BIFIDOBACTERIUM SPECIES LYSATE
[patent_app_type] => utility
[patent_app_number] => 18/292746
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292746
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292746 | COSMETIC TREATMENT METHOD COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING AT LEAST ONE ANTIOXIDANT AND A BIFIDOBACTERIUM SPECIES LYSATE | Jul 21, 2022 | Pending |
Array
(
[id] => 18707715
[patent_doc_number] => 20230330298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => Aromatherapeutic Honey Bandage
[patent_app_type] => utility
[patent_app_number] => 17/868804
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17868804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/868804 | Aromatherapeutic Honey Bandage | Jul 19, 2022 | Pending |
Array
(
[id] => 18792592
[patent_doc_number] => 11826325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection
[patent_app_type] => utility
[patent_app_number] => 17/860889
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 7854
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860889 | Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection | Jul 7, 2022 | Issued |